Search Within


Applied Filters:
Showing 1-4 of 4 results for "215-218-3" within Papers
Mohamad K Nusier et al.
Neuro endocrinology letters, 28(5), 699-703 (2007-11-07)
Factor V Leiden and prothrombin G20210A are related genetic risk factors for venous thromboembolism (VTE). Analysis for both mutations is increasingly being performed on patients exhibiting hypercoagulability. The objective of this study was to determine the prevalence of factor V
S M Twigg et al.
The Journal of biological chemistry, 273(44), 28791-28798 (1998-10-24)
We have recently shown that insulin-like growth factor (IGF)-binding protein 5 forms ternary complexes with IGF-I or IGF-II and the acid-labile subunit (ALS) (Twigg, S. M., and Baxter, R. C. (1998) J. Biol. Chem. 273, 6074-6079). Because IGF-binding protein 3
L J Schedlich et al.
The Journal of biological chemistry, 275(31), 23462-23470 (2000-05-16)
Although insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 are known to modulate cell growth by reversibly sequestering extracellular insulin-like growth factors, several reports have suggested that IGFBP-3, and possibly also IGFBP-5, have important insulin-like growth factor-independent effects on cell growth.
K H Kondo et al.
European journal of biochemistry, 219(1-2), 357-363 (1994-01-15)
The enzyme delta 4-3-oxosteroid 5 beta-reductase (3-oxo-5 beta-steroid: NADP+ oxidoreductase and 4,5 beta-dihydrocortisone: NADP+ delta 4-oxidoreductase) catalyzes the reduction of the delta 4 double bond of bile acid intermediates and steroid hormones carrying the delta 4-3-one structure in the A/B
Page 1 of 1